Lee Su-Leng Tan
CIK: 0002141883
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BGLC
BioNexus Gene Lab Corp
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
About Tan Lee Su-Leng
Tan Lee Su-Leng (SEC CIK 0002141883) files insider reports with the SEC as Chief Executive Officer of BioNexus Gene Lab Corp (BGLC).
Signal8 holds 1 ownership filing by Tan Lee Su-Leng, a Form 4, filed on Aug 14, 2026. Those filings report 1 transaction, the latest on Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tan Lee Su-Leng's filings is in KUALA LUMPUR.
Recent filings by Tan Lee Su-Leng
- Aug 13, 2026: Grant or award of BGLC shares (Form 4, code A).
Other insiders filing for BioNexus Gene Lab Corp (BGLC)
- Yap Chee Keong, Director
- Bin Abdul Hamid Muhammad Azrul, Director
- Chong Set Fui, Chief Financial Officer
- Low Jook Yuen, Director
- FIDELION DIAGNOSTICS PTE. LTD., Officer